Literature DB >> 30596891

Extracellular vesicles derived from endometrial human mesenchymal stem cells enhance embryo yield and quality in an aged murine model†.

Federica Marinaro1, Beatriz Macías-García2, Francisco Miguel Sánchez-Margallo1,3, Rebeca Blázquez1,3, Verónica Álvarez1, Elvira Matilla2, Nuria Hernández2, María Gómez-Serrano3,4, Inmaculada Jorge3,4, Jesús Vázquez3,4, Lauro González-Fernández5, Eva Pericuesta6, Alfonso Gutiérrez-Adán6, Javier G Casado1,3.   

Abstract

Advanced age is a risk factor undermining women's fertility. Hence, the optimization of assisted reproduction techniques is an interdisciplinary challenge that requires the improvement of in vitro culture systems. Here, we hypothesize that supplementation of embryo culture medium with extracellular vesicles from endometrial-derived mesenchymal stem cells (EV-endMSCs) may have a positive impact on the embryo competence of aged oocytes. In this work, 24 weeks old B6D2 female mice were used as egg donors and in vitro fertilization assays were performed using males from the same strain (8-12 weeks); the presumptive zygotes were incubated in the presence of 0, 10, 20, 40, or 80 μg/ml of EV-endMSCs. The results from the proteomic analysis of EV-endMSCs and the classification by Reactome pathways allowed us to identify proteins closely related with the fertilization process. Moreover, in our aged murine model, the supplementation of the embryo culture medium with EV-endMSCs improved the developmental competence of the embryos as well as the total blastomere count. Finally, gene expression analysis of murine blastocysts showed significant changes on core genes related to cellular response to oxidative stress, metabolism, placentation, and trophectoderm/inner cell mass formation. In summary, we demonstrate that EV-endMSCs increase the quality of the embryos, and according to proteomic and genomic analysis, presumably by modulating the expression of antioxidant enzymes and promoting pluripotent activity. Therefore, EV-endMSCs could be a valuable tool in human assisted reproduction improving the developmental competence of aged oocytes and increasing the odds of implantation and subsequent delivery.
© The Author(s) 2018. Published by Oxford University Press on behalf of Society for the Study of Reproduction.

Entities:  

Keywords:  aging; embryo culture; gene expression; oxidative stress; proteomics; stem cells

Mesh:

Year:  2019        PMID: 30596891     DOI: 10.1093/biolre/ioy263

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  15 in total

1.  Endometrial extracellular vesicles of recurrent implantation failure patients inhibit the proliferation, migration, and invasion of HTR8/SVneo cells.

Authors:  Chang Liu; Linshuang Li; Meng Wang; Shike Shui; Haixia Yao; Cong Sui; Hanwang Zhang
Journal:  J Assist Reprod Genet       Date:  2021-02-01       Impact factor: 3.412

2.  Study of the Metabolomics of Equine Preovulatory Follicular Fluid: A Way to Improve Current In Vitro Maturation Media.

Authors:  Pablo Fernández-Hernández; María Jesús Sánchez-Calabuig; Luis Jesús García-Marín; María J Bragado; Alfonso Gutiérrez-Adán; Óscar Millet; Chiara Bruzzone; Lauro González-Fernández; Beatriz Macías-García
Journal:  Animals (Basel)       Date:  2020-05-19       Impact factor: 2.752

3.  Unraveling the Molecular Signature of Extracellular Vesicles From Endometrial-Derived Mesenchymal Stem Cells: Potential Modulatory Effects and Therapeutic Applications.

Authors:  Federica Marinaro; María Gómez-Serrano; Inmaculada Jorge; Juan Carlos Silla-Castro; Jesús Vázquez; Francisco Miguel Sánchez-Margallo; Rebeca Blázquez; Esther López; Verónica Álvarez; Javier G Casado
Journal:  Front Bioeng Biotechnol       Date:  2019-12-20

4.  Extracellular Vesicles Derived from Mesenchymal Stem Cells Recover Fertility of Premature Ovarian Insufficiency Mice and the Effects on their Offspring.

Authors:  Conghui Liu; Huiqun Yin; Hong Jiang; Xin Du; Cunli Wang; Yingchun Liu; Yu Li; Ziling Yang
Journal:  Cell Transplant       Date:  2020 Jan-Dec       Impact factor: 4.064

5.  IFN-Gamma and TNF-Alpha as a Priming Strategy to Enhance the Immunomodulatory Capacity of Secretomes from Menstrual Blood-Derived Stromal Cells.

Authors:  María Ángeles de Pedro; María Gómez-Serrano; Federica Marinaro; Esther López; María Pulido; Christian Preußer; Elke Pogge von Strandmann; Francisco Miguel Sánchez-Margallo; Verónica Álvarez; Javier G Casado
Journal:  Int J Mol Sci       Date:  2021-11-10       Impact factor: 5.923

Review 6.  Understanding menstrual blood-derived stromal/stem cells: Definition and properties. Are we rushing into their therapeutic applications?

Authors:  Alicia Sanchez-Mata; Elena Gonzalez-Muñoz
Journal:  iScience       Date:  2021-11-22

7.  The Intrapericardial Delivery of Extracellular Vesicles from Cardiosphere-Derived Cells Stimulates M2 Polarization during the Acute Phase of Porcine Myocardial Infarction.

Authors:  Esther López; Rebeca Blázquez; Federica Marinaro; Verónica Álvarez; Virginia Blanco; Claudia Báez; Irene González; Ana Abad; Beatriz Moreno; Francisco Miguel Sánchez-Margallo; Verónica Crisóstomo; Javier García Casado
Journal:  Stem Cell Rev Rep       Date:  2020-06       Impact factor: 5.739

Review 8.  Small extracellular vesicles from menstrual blood-derived mesenchymal stem cells (MenSCs) as a novel therapeutic impetus in regenerative medicine.

Authors:  Lijun Chen; Jingjing Qu; Quanhui Mei; Xin Chen; Yangxin Fang; Lu Chen; Yifei Li; Charlie Xiang
Journal:  Stem Cell Res Ther       Date:  2021-08-03       Impact factor: 6.832

Review 9.  The Complicated Effects of Extracellular Vesicles and Their Cargos on Embryo Implantation.

Authors:  Nan-Xing Jiang; Xue-Lian Li
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-04       Impact factor: 5.555

Review 10.  Therapeutic Role of Mesenchymal Stem Cell-Derived Extracellular Vesicles in Female Reproductive Diseases.

Authors:  Zhiqi Liao; Chang Liu; Lan Wang; Cong Sui; Hanwang Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-23       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.